Pharmacokinetics, safety and tolerability of the novel β‐hCG derived immunomodulatory compound, EA‐230

AIMS: EA‐230 is a newly developed synthetic linear tetrapeptide (AQGV) derived from the chorionic gonadotropin hormone (β‐hCG). We investigated the pharmacokinetics, safety and tolerability of EA‐230 in healthy subjects using different administration strategies. METHODS: Double‐blind, randomized, pl...

Descripción completa

Detalles Bibliográficos
Autores principales: van Groenendael, Roger, Aarnoutse, Rob, Kox, Matthijs, van Eijk, Lucas, Pickkers, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595371/
https://www.ncbi.nlm.nih.gov/pubmed/30924163
http://dx.doi.org/10.1111/bcp.13942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595371/
https://www.ncbi.nlm.nih.gov/pubmed/30924163
http://dx.doi.org/10.1111/bcp.13942

Ejemplares similares